TYMS and cancer: The increased ability of TS-deficient cells to form metastasis was independently confirmed by an in vitro real-time extravasation assay, which monitors how fast the cancer cells penetrate a monolayer of human umbilical vein endothelial cells (HUVEC) (Fig. 4c).